MedPath

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

Phase 3
Recruiting
Conditions
Chronic Kidney Disease
Proteinuria
Interventions
Registration Number
NCT05196035
Lead Sponsor
Bayer
Brief Summary

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine.

The kidneys filter waste and fluid from the blood to form urine. In children with CKD, the kidney´s filters do not work as well as they should. This can lead to accumulation of waste and fluid in the body and proteinuria. CKD can lead to other medical problems, such as high blood pressure, also known as hypertension. Vice versa, hypertension and proteinuria can also contribute to worsening of CKD. Therefore, the treatment of CKD aims to control blood pressure and proteinuria. There are treatments available for doctors to prescribe to children with CKD and hypertension and/or proteinuria. These include "angiotensin-converting enzyme inhibitors" (ACEI) and "angiotensin receptor blockers" (ARB). Both ACEI and ARB can improve kidney function by helping the renin-angiotensin-aldosterone system (RAAS) to work normally. The RAAS is a system that works with the kidneys to control blood pressure and the balance of fluid and electrolytes in the blood. In people with CKD, the RAAS is often too active, which can stop the kidneys from working properly and cause hypertension and proteinuria. However, ACEI or ARB treatment alone does not work for all patients with CKD as they only target the angiotensin part of the renin-angiotensin-aldosterone system.

The study treatment, finerenone, is expected to help control RAAS overactivation together with an ACEI or ARB.

So, the researchers in this study want to learn more about whether finerenone given in addition to either an ACEI or ARB can help their kidney function.

The main purpose of this study is to learn more about whether finerenone added to either ACEI or ARB can help reduce the amount of protein in the participants' urine more than a placebo. A placebo looks like a treatment but does not have any medicine in it. Participants will also continue to receive their other medications.

To see how the treatment work, the doctors will take samples of the participants' urine to measure their protein levels before and during taking treatment and after their last treatment. In addition, blood samples will be taken to monitor kidney function, electrolytes and the amount of finerenone in the blood as well as for other tests.

This study will include children with CKD and proteinuria aged from 6 months up to less than 18 years. The participants will take:

* either finerenone or the placebo, in addition to

* either ACEI or ARB, whichever they take as part of their normal treatment

Two visits are required up to 104 days, to check whether a child can take part in the treatment phase of the study. If participants qualify for the treatment phase, they will then undergo treatment for about 180 days. During this time, they will visit the study site at least 7 times. During these visits, the participants will:

* have their blood pressure, heart rate, temperature, height and weight measured

* have blood and urine samples taken

* have physical examinations

* have their heart examined by an electrocardiogram and echocardiography (a sonogram of the heart)

* answer questions about their medication and whether they have any adverse events , or have their parents or guardians answer

* answer questions about how they are feeling, or have their parents or guardians answer

* answer question about how they like the study medication, or have their parents or guardians answer

The doctors will keep track of any adverse events. An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments.

The doctors will check the participants' health about 30 days after the participants take their last treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
219
Inclusion Criteria
  • Participants must be 6 months to <18 years old at the time when the informed consent/assent is signed

  • Participants must have a clinical diagnosis of chronic kidney disease (CKD) at screening which is defined as

    • CKD stages 1-3 (eGFR ≥30 mL/min/1.73m^2) for children ≥1 year to <18 years of age or

    • a serum creatinine ≤ 0.40 mg/dL for infants 6 months to < 1 year of age and

    • severely increased proteinuria as defined by

      • Urinary protein-to-creatinine ratio (UPCR) of ≥ 0.50 g/g in participants ≥ 2 years with CKD stage 2 and 3 or
      • UPCR ≥ 1.0 g/g for patients < 2 years of age or ≥ 2 years of age and with CKD stage 1
  • Participants must have stable kidney function between screening and D0 defined as:

    • no increase or decrease in eGFR ≥ 15% for children ≥1 year or
    • no increase or decrease in creatinine ≥ 0.10 mg/dL for children <1 year
  • Treated with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) at optimized doses defined as maximally tolerable doses within the recommended dose range according to guidelines on blood pressure management, unchanged for at least 30 days prior to screening

  • K+ ≤5.0 mmol/L for children ≥2 years of age at both screening and D0, and ≤5.3 mmol/L for children <2 years of age at both screening and D0

Exclusion Criteria
  • Planned urological surgery expected to influence renal function
  • Children with hemolytic uremic syndrome (HUS) diagnosed ≤6 months prior to screening
  • Patients with nephrotic syndrome receiving albumin infusions within the last 6 months prior to screening
  • Patients who are candidates for renal transplantation, i.e., a kidney transplantation scheduled within the study time frame
  • Renal allograft in place
  • Bilateral renal artery stenosis
  • Acute kidney injury requiring dialysis within 6 months prior to screening
  • Systemic hypertension stage 2 in children ≥1 year of age defined according to guidelines on blood pressure management at screening or randomization
  • Systolic blood pressure (SBP) above 110 mmHg in infants 6 months to <1 year of age at screening or randomization
  • Systemic hypotension defined as a systolic blood pressure below the 5th percentile for age, sex and height at either screening or randomization but no lower than 80 mmHg (although for some participants the 5th percentile of SBP is < 80 mmHg they must be excluded if their SBP is <80 mmHg)
  • Participants with immune-mediated CKD using rituximab, cyclophosphamide, abatacept, or high-dose glucocorticoids, within <6 months prior to screening

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Finerenone (Kerendia, BAY94-8862)Finerenone (Kerendia, BAY94-8862)Participants will receive finerenone treatment.
PlaceboPlaceboParticipants will receive placebo to finerenone.
Primary Outcome Measures
NameTimeMethod
Urinary protein-to-creatinine ratio (UPCR) reduction of at least 30% from baseline to day 180±7From baseline to day 180±7

Proportion of participants at day 180±7 with a \>=30% reduction in UPCR compared to baseline.

Secondary Outcome Measures
NameTimeMethod
Change in systolic blood pressure from baseline to day 180±7From baseline to day 180±7
Mean reduction from baseline to day 180±7 in UPCRFrom baseline to day 180±7

Percent change from baseline to day 180±7 in UPCR will be calculated.

Pharmacokinetics (PK) finerenone Cmax, mdPre-dose, post-dose (1.5-5 hours after intake of intervention), up to day 180±7

Maximum observed finerenone concentration in plasma after multiple doses.

Number participants with treatment emergent adverse events (TEAEs)From the start of study intervention to last study intervention + 3 days (up to 190 days)

Below sub-categories will be considered:

1. Serious Treatment Emergent Adverse Events (TEAEs)

2. TEAEs and serious TEAEs leading to discontinuation of treatment

3. Study drug related TEAEs and serious TEAEs

4. TEAEs categorized by severity (mild, moderate, severe)

5. TEAEs by maximum intensity

6. Number of participants hospitalized with hyperkalemia,

7. Number of participants discontinuing due to hyperkalemia,

8. Number of participants with hospitalization for worsening of renal function

9. Number of participants discontinuing due to worsening of renal function

Change in eGFR from baseline to day 180±7From baseline to day 180±7

Estimated glomerular filtration rate (eGFR)

Taste and texture questionnaire of the pediatric formulationOn day 30±3 and day 180±7
Pharmacokinetics (PK) finerenone AUCτ,mdPre-dose, post-dose (1.5-5 hours after intake of intervention), up to day 180±7

Area under the curve for finerenone concentration in plasma after multiple doses.

Change in serum potassium levels from baseline to day 180±7From baseline to day 180±7
Change in serum creatinine from baseline to day 180±7From baseline to day 180±7
Change in UACR from baseline to day 180±7From baseline to day 180±7

Urinary albumin-to-creatinine ratio (UACR)

Trial Locations

Locations (156)

Rigshospitalet - Børn og Unge

🇩🇰

Copenhagen, Denmark

Pecsi Tudomanyegyetem Klinikai Kozpont

🇭🇺

Pecs, Hungary

SZTE ÁOK Szent Györgyi Albert Klinikai Kozpont

🇭🇺

Szeged, Hungary

H Univ. 12 de Octubre | Unidad Pediátrica Inv y EECC (UPIC)

🇪🇸

Madrid, Spain

Hospital la Paz

🇪🇸

Madrid, Spain

Children's Hospital of Philadelphia - Nephrology

🇺🇸

Philadelphia, Pennsylvania, United States

Univ of Texas Health Science Center | Nephrology Res Dept

🇺🇸

San Antonio, Texas, United States

Primary Children's Hospital

🇺🇸

Salt Lake City, Utah, United States

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

Instituto Universitario Hospital Italiano de Buenos Aires | Hospital Italiano de Buenos Aires - Neurology Department

🇦🇷

Ciudad Autonoma de Buenos Aire, Ciudad Auton. De Buenos Aires, Argentina

Hospital General de Ninos Ricardo Gutierrez | Pediatric Nephrology Department

🇦🇷

Ciudad Autonoma de Buenos Aire, Ciudad Auton. De Buenos Aires, Argentina

Centro de Rehabilitacion Cardiovascular | San Luis, Argentina

🇦🇷

San Luis, Provincia De San Luis, Argentina

Clinica de Nefrologia, Urologia y Enfermedades Cardiovascualares | Santa Fe, Argentina

🇦🇷

Santa Fe, Provincia De Santa Fe, Argentina

Hospital de Pediatría Juan P. Garrahan

🇦🇷

Buenos Aires, Argentina

Hospital General de Ninos Pedro de Elizalde | Nephrology Department

🇦🇷

Buenos Aires, Argentina

The Children's Hospital at Westmead

🇦🇺

Westmead, New South Wales, Australia

Queensland Children's Hospital

🇦🇺

South Brisbane, Queensland, Australia

Monash Children's Hospital

🇦🇺

Clayton, Victoria, Australia

Royal Children's Hospital Melbourne

🇦🇺

Parkville, Victoria, Australia

Kepler Universitätsklinikum Campus IV

🇦🇹

Linz, Oberösterreich, Austria

Medizinische Univ Graz | Kinder & Jugendheilkunde

🇦🇹

Graz, Steiermark, Austria

Uniklinikum Salzburg - Landeskrankenhaus

🇦🇹

Salzburg, Austria

AKH Wien | Kinder & Jugendheilkunde, Kindernephrologie

🇦🇹

Wien, Austria

Huderf / Ukzkf

🇧🇪

Bruxelles - Brussel, Belgium

CU Saint-Luc/UZ St-Luc

🇧🇪

Bruxelles - Brussel, Belgium

UZ Gent

🇧🇪

Gent, Belgium

UZ Gasthuisberg - Pediatric Nephrology

🇧🇪

Leuven, Belgium

CHC Montlégia - Pediatrics

🇧🇪

Liège, Belgium

Santa Casa de Misericórdia de Belo Horizonte

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

Hospital Pequeno Principe

🇧🇷

Curitiba, Parana, Brazil

Hosp Clínicas Facult. Med. de Ribeirão Preto / USP

🇧🇷

Ribeirão Preto/SP, Sao Paulo, Brazil

Hospital PUC-Campinas | Centro de Pesquisa Clínica Sao Lucas

🇧🇷

São Paulo, Sao Paulo, Brazil

Hospital Infantil Sabará - Instituto PENSI - Pesquisa e Ensino em Saúde Infantil

🇧🇷

Sao Paulo, SP, Brazil

Instituto da Crianca e do Adolescente

🇧🇷

Sao Paulo, Brazil

UMHAT Sveti Georgi

🇧🇬

Plovdiv, Bulgaria

SHATPD "Prof. Ivan Mitev"

🇧🇬

Sofia, Bulgaria

MHAT prof. Stoyan Kirkovitch AD

🇧🇬

Stara Zagora, Bulgaria

Alberta Children's Hospital - Nephrology Clinic

🇨🇦

Calgary, Alberta, Canada

McMaster Children's Hospital

🇨🇦

Hamilton, Ontario, Canada

The Hospital for Sick Children (SickKids)

🇨🇦

Toronto, Ontario, Canada

CHU Sainte-Justine

🇨🇦

Montreal, Quebec, Canada

Všeobecná fakultní nemocnice v Praze

🇨🇿

Praha 2, Czechia

Fakultni nemocnice v Motole

🇨🇿

Praha 5, Czechia

Odense Universitetshospital - HC Andersen Børne og Ungehospital

🇩🇰

Odense C, Denmark

Aarhus Universitetshospital - Børn og Unge

🇩🇰

Århus N, Denmark

Helsinki University Hospital | Children's Hospital - Clinical Trial Unit, Nephrology Department

🇫🇮

Helsinki, Finland

Tays Service Centre | Tampere University Hospital - Pediatric Early Phase Clinical Trials Unit

🇫🇮

Tampere, Finland

Turun yliopistollinen keskussairaala

🇫🇮

Turku, Finland

Hôpital Pellegrin - Bordeaux

🇫🇷

BORDEAUX cedex, France

CHU de Lyon - Hopital Femme Mère Enfant

🇫🇷

Bron, France

Hopital Arnaud de Villeneuve CHU Montpellier

🇫🇷

Montpellier, France

Hopital Robert Debre

🇫🇷

Paris, France

CHU Strasbourg - Hopital Hautepierre

🇫🇷

Strasbourg, France

Hôpital des Enfants

🇫🇷

TOULOUSE Cedex 9, France

Universitätsklinikum Heidelberg

🇩🇪

Heidelberg, Baden-Württemberg, Germany

Universitätsklinikum Erlangen

🇩🇪

Erlangen, Bayern, Germany

Medizinische Hochschule Hannover (MHH)

🇩🇪

Hannover, Niedersachsen, Germany

Kindernierenzentrum Bonn

🇩🇪

Bonn, Nordrhein-Westfalen, Germany

Universitätsklinikum Essen

🇩🇪

Essen, Nordrhein-Westfalen, Germany

Universitaetsklinikum Muenster

🇩🇪

Münster, Nordrhein-Westfalen, Germany

Charité / Pädiatrie

🇩🇪

Berlin, Germany

Universitätsklinikum Hamburg Eppendorf (UKE)

🇩🇪

Hamburg, Germany

Children's Hospital of Athens Agia Sofia - Pediatric Nephrology Department

🇬🇷

Athens, Greece

Children's Hospital of Athens P&A Kyriakou - Pediatric Nephrology Department

🇬🇷

Athens, Greece

University General Hospital of Heraklion - Department of Paediatrics

🇬🇷

Heraklion, Greece

Univ. General Hospital of Ioannina - Department of Paediatrics, Nephrology Unit

🇬🇷

Ioannina, Greece

Hippokration General Hospital of Thessaloniki - 3rd Department of Paediatrics, Nephrology Unit'

🇬🇷

Thessaloniki, Greece

Semmelweis University

🇭🇺

Budapest, Hungary

Debreceni Egyetem Klinikai Kozpont

🇭🇺

Debrecen, Hungary

St. John's National Academy of Health Sciences

🇮🇳

Bangalore, India

All India Institute of Medical Sciences (AIIMS) - New Delhi

🇮🇳

Delhi, India

NRS Medical college

🇮🇳

Kolkata, India

Clalit Health | Soroka Medical Center - Internal Medicine Department

🇮🇱

Beer Sheva, Israel

Wilf Children's Hospital Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

Health Corporation of Galilee Medical Center

🇮🇱

Nahariya, Israel

Clalit Health Services Schneider Children's Medical Center

🇮🇱

Petach Tikva, Israel

Dana-Dwek Children's Hospital

🇮🇱

Tel Aviv, Israel

Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - Pediatria

🇮🇹

Bologna, Emilia-Romagna, Italy

Ospedale Pediatrico Bambino Gesù - Nefrologia

🇮🇹

Roma, Lazio, Italy

IRCCS Istituto Giannina Gaslini - Nefrologia e Trapianto Rene

🇮🇹

Genova, Liguria, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Nefrologia e Dialisi Pediatrica, Trapianti di Rene

🇮🇹

Milano, Lombardia, Italy

Azienda Ospedaliera Universitaria Meyer IRCCS - Nefrologia e Dialisi

🇮🇹

Firenze, Italy

A.O.U. Città della Salute e della Scienza di Torino_Regina Margherita - Nefrologia Pediatrica

🇮🇹

Torino, Italy

Kyungpook National University Hospital

🇰🇷

Daegu, Daegu Gwang''yeogsi, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggido, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Yangsan-si, Gyeongsangnamdo, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Seoul Teugbyeolsi, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Seoul Teugbyeolsi, Korea, Republic of

Hospital of LT University of Health Sciences Kaunas Clinics

🇱🇹

Kaunas, Lithuania

Klaipeda Children's Hospital

🇱🇹

Klaipeda, Lithuania

Vilnius University Hospital Santaros Klinikos Children's Hospital Paediatrics Centre

🇱🇹

Vilnius, Lithuania

Hospital Tunku Azizah

🇲🇾

Wilayah Persekutuan, Kuala Lumpur, Malaysia

Hospital Tuanku Ja'afar

🇲🇾

Seremban, Negeri Sembilan, Malaysia

Hospital Selayang

🇲🇾

Shah Alam, Selangor, Malaysia

Sunway Medical Centre

🇲🇾

Subang Jaya, Selangor, Malaysia

Hospital Universiti Sains Malaysia

🇲🇾

Kelantan, Malaysia

Sitio Alfredo Chew Wong | Aguascalientes, Mexico

🇲🇽

Aguascalientes, Agguascalientes, Mexico

Instituto Veracruzano en Investigación Clinica SC

🇲🇽

Ciudad de Mexico, Distrito Federal, Mexico

Hospital Infantil de México "Dr. Federico Gómez"

🇲🇽

México D.F., Distrito Federal, Mexico

Instituto Nacional de Pediatría

🇲🇽

México, D.F., Distrito Federal, Mexico

Hospital Regional de Alta Especialidad Ixtapaluca

🇲🇽

Ixtapaluca, Estado De Mexico, Mexico

Universitair Medisch Centrum Groningen

🇳🇱

Groningen, Netherlands

Universitair Medisch Centrum St. Radboud

🇳🇱

Nijmegen, Netherlands

University Medical Center Utrecht

🇳🇱

Utrecht, Netherlands

Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa

🇵🇱

Bialystok, Poland

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdansk, Poland

Uniwersytecki Szpital Dzieciecy w Krakowie

🇵🇱

Krakow, Poland

Instytut Centrum Zdrowia Matki Polki

🇵🇱

Lodz, Poland

Dzieciecy Szpital Kliniczny im. Jozefa Brudzinskiego

🇵🇱

Warszawa, Poland

Instytut "Pomnik - Centrum Zdrowia Dziecka"

🇵🇱

Warszawa, Poland

Uniwersytecki Szpital Kliniczny UM we Wroclawiu

🇵🇱

Wroclaw, Poland

Hospital Santa Maria | Centro de Investigacao Clinica

🇵🇹

Missing, Lisboa, Portugal

Centro Clinico Academico Braga | Braga, Portugal

🇵🇹

Braga, Portugal

Hospital Pediátrico de Coimbra I ULS Coimbra

🇵🇹

Coimbra, Portugal

Centro Hospitalar Universitario do Porto | Servico de Investigacao Clinica

🇵🇹

Porto, Portugal

Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit

🇿🇦

Soweto, Gauteng, South Africa

Ciutat Sanitaria i Universitaria de la Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital de Sant Joan de Déu

🇪🇸

Barcelona, Spain

University Hospital of Malaga | Unidad de Gestion Clinica de Pediatria

🇪🇸

Málaga, Spain

Virgen del Rocio University Hospital | Pediatric Nephrology Unit

🇪🇸

Sevilla, Spain

Skånes Universitetssjukhus Lund - Barnnefroenheten

🇸🇪

Lund, Sweden

Karolinska University Hospital

🇸🇪

Stockholm, Sweden

Uppsala University Hospital

🇸🇪

Uppsala, Sweden

Universitäts-Kinderspital UKBB

🇨🇭

Basel, Basel-Stadt, Switzerland

Centre Hospitalier Universitaire Vaudois (CHUV)

🇨🇭

Lausanne, Vaud, Switzerland

Hopital des Enfants HUG

🇨🇭

Geneva, Switzerland

Chang Gung Memorial Hospital (CGMH) - Kaohsiung Branch

🇨🇳

Guishan, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

Cukurova Univ. Tip. Fak. Balcali Hastanesi

🇹🇷

Adana, Turkey

Hacettepe Universitesi Tip Fakultesi

🇹🇷

Ankara, Turkey

Baskent Universitesi Tip Fakultesi Hastanesi

🇹🇷

Ankara, Turkey

Gazi Universitesi Tip Fakultesi

🇹🇷

Ankara, Turkey

Health Ministry Of Türkiye Republic Ankara Bilkent City Hospital

🇹🇷

Ankara, Turkey

Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Pediatrics

🇹🇷

Istanbul, Turkey

Istanbul Universitesi Cerrahpasa - Cocuk Nefrolojisi

🇹🇷

Istanbul, Turkey

Marmara University Medical Faculty | Pediatric Nephrology

🇹🇷

Istanbul, Turkey

Birmingham Children's Hospital

🇬🇧

Birmingham, West Midlands, United Kingdom

Royal Hospital for Children

🇬🇧

Glasgow, United Kingdom

Great Ormond Street Hospital for Children

🇬🇧

London, United Kingdom

Royal Manchester Children's Hospital

🇬🇧

Manchester, United Kingdom

Queens Medical Centre

🇬🇧

Nottingham, United Kingdom

Phoenix Children's Hospital | Main - Transplant Department

🇺🇸

Phoenix, Arizona, United States

University of California San Diego (UCSD)

🇺🇸

La Jolla, California, United States

Lucille Packard Children's Hospital Stanford - Pediatric Nephrology

🇺🇸

Palo Alto, California, United States

Children's National Medical Center - Nephrology

🇺🇸

Washington, District of Columbia, United States

South Broward Hosp. District dba Memorial Healthcare System

🇺🇸

Hollywood, Florida, United States

Emory University Hospital/Children's Healthcare of Atlanta - Nephrology

🇺🇸

Atlanta, Georgia, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

The Charlotte R. Bloomberg Children's Center Building - Nephrology

🇺🇸

Baltimore, Maryland, United States

Boston Children's Hospital - Main Campus - Nephrology

🇺🇸

Boston, Massachusetts, United States

Children's Mercy Hospital Kansas City - Nephrology

🇺🇸

Kansas City, Missouri, United States

Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension

🇺🇸

Cincinnati, Ohio, United States

Cleveland Clinic | Pediatric Nephrology

🇺🇸

Cleveland, Ohio, United States

Nationwide Children's Hospital - Nephrology

🇺🇸

Columbus, Ohio, United States

Oregon Health and Science Univ | Doernbecher Childrens Hosp

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath